These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 20025838)

  • 1. Second meeting of the French CEIP (Centres d'Evaluation et d'Information sur la Pharmacodépendance). Part I: how to evaluate and prevent the abuse and dependence on hypnotic/anxiolytic drugs?
    Micallef-Roll J; Lapeyre-Mestre M;
    Therapie; 2009; 64(6):355-64. PubMed ID: 20025838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Second Meeting of the French CEIP (Centres d'Évaluation et d'Information sur la Pharmacodépendance). Part I: How to Evaluate and Prevent the Abuse and Dependence on Hypnotic/Anxiolytic Drugs?
    Micallef-Roll J; Lapeyre-Mestre M;
    Therapie; 2009; 64(6):355-64. PubMed ID: 27392928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [First meeting of the French CEIP (centres d'évaluation et d'information sur la pharmacodépendance). Assessment of the abuse and pharmacodependence potential during drug development].
    Micaleff J; Jolliet P; Victorri-Vigneau C; Mallaret M; Richard N; Haramburu F; Lapeyre-Mestre M
    Therapie; 2008; 63(1):55-65. PubMed ID: 18387277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Second meeting of the French CEIP (Centres d'Evaluation et d'Information sur la Pharmacodépendance). Part II: benzodiazepine withdrawal.
    Authier N; Boucher A; Lamaison D; Llorca PM; Descotes J; Eschalier A
    Therapie; 2009; 64(6):365-70. PubMed ID: 20025839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicentre study for validation of the French addictovigilance network reports assessment tool.
    Victorri-Vigneau C; Hardouin JB; Rousselet M; Gerardin M; Guerlais M; Guillou M; Bronnec M; Sébille V; Jolliet P;
    Br J Clin Pharmacol; 2016 Oct; 82(4):1030-9. PubMed ID: 27302554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Abuse of licit and illicit psychoactive substances in children and teenagers in the PACA Region (Southeastern France)].
    Arditti J; Spadari M; Camprasse MA; Dalecky C; Bourdon JH
    Therapie; 2004; 59(6):595-7. PubMed ID: 15789820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Use of the health insurance database by the centres for evaluation and information on pharmacodependance: examples, interests and future prospects].
    Micallef J; Pradel V; Thirion X; Jolliet P; Lapeyre-Mestre M
    Therapie; 2004; 59(6):581-8. PubMed ID: 15789818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence of zolpidem abuse and dependence: results of the French Centre for Evaluation and Information on Pharmacodependence (CEIP) network survey.
    Victorri-Vigneau C; Dailly E; Veyrac G; Jolliet P
    Br J Clin Pharmacol; 2007 Aug; 64(2):198-209. PubMed ID: 17324242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multimorbidity and use of hypnotic and anxiolytic drugs: cross-sectional and follow-up study in primary healthcare in Iceland.
    Linnet K; Gudmundsson LS; Birgisdottir FG; Sigurdsson EL; Johannsson M; Tomasdottir MO; Sigurdsson JA
    BMC Fam Pract; 2016 Jun; 17():69. PubMed ID: 27267943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence of clonazepam abuse liability: results of the tools developed by the French Centers for Evaluation and Information on Pharmacodependence (CEIP) network.
    Frauger E; Pauly V; Pradel V; Rouby F; Arditti J; Thirion X; Lapeyre Mestre M; Micallef J
    Fundam Clin Pharmacol; 2011 Oct; 25(5):633-41. PubMed ID: 21077937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substance dependence and the use of pro re nata anxiolytic/hypnotic drugs in a hospital setting.
    D'Mello DA; Lyon DE; Colenda CC; Fernandes CL
    Addict Behav; 2000; 25(3):441-3. PubMed ID: 10890298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug misuse and diversion in adults prescribed anxiolytics and sedatives.
    McLarnon ME; Monaghan TL; Stewart SH; Barrett SP
    Pharmacotherapy; 2011 Mar; 31(3):262-72. PubMed ID: 21361736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study of narcotics and buprenorphine prescriptions in the Provence-Alps-Côte d'Azur region].
    Millet P; Monnier B; Affaton MF; Campocasso J; Arditti J; Jouglard J
    Therapie; 1998; 53(2):107-12. PubMed ID: 9773109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Scoring pharmacodependence seriousness: a novel CEIP's evaluation tool].
    Victorri-Vigneau C; Jolliet P
    Therapie; 2006; 61(6):517-22. PubMed ID: 17348608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anxiolytic and hypnotic drug misuse in Thailand: findings from a national household survey.
    Assanangkornchai S; Sam-Angsri N; Rerngpongpan S; Edwards JG
    Drug Alcohol Rev; 2010 Jan; 29(1):101-11. PubMed ID: 20078690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical features of patients with designer-drug-related disorder in Japan: a comparison with patients with methamphetamine- and hypnotic/anxiolytic-related disorders.
    Matsumoto T; Tachimori H; Tanibuchi Y; Takano A; Wada K
    Psychiatry Clin Neurosci; 2014 May; 68(5):374-82. PubMed ID: 24405505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anxiolytic agents and hypnotic drugs in Bretagne. Pharmaco-epidemiological study].
    Nguyen JM; Allain H; Martinet JP; Beneton C; Reymann JM; Decombe R
    Ann Med Interne (Paris); 1991; 142(3):163-7. PubMed ID: 1677240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anxiolytics, hypnotics, and antidepressants dispensed to adolescents in a French region in 2002.
    Mancini J; Thirion X; Masut A; Saillard C; Pradel V; Romain F; Pastor MJ; Coudert C; Micallef J
    Pharmacoepidemiol Drug Saf; 2006 Jul; 15(7):494-503. PubMed ID: 16700077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anxiolytic and hypnotic use in 376 psychiatric inpatients. GERMED Neuropsychotropics Group.
    Hardy P; Payan C; Bisserbe JC; Lepine JP
    Eur Psychiatry; 1999 Mar; 14(1):25-32. PubMed ID: 10572322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacoepidemiological characterization of psychotropic drugs consumption using a latent class analysis.
    Wainstein L; Victorri-Vigneau C; Sébille V; Hardouin JB; Feuillet F; Pivette J; Chaslerie A; Jolliet P
    Int Clin Psychopharmacol; 2011 Jan; 26(1):54-62. PubMed ID: 20881845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.